Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
29 hedge funds and large institutions have $10.8M invested in Nemaura Medical, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 13 closing their positions.
31% more capital invested
Capital invested by funds: $8.25M → $10.8M (+$2.55M)
19% more call options, than puts
Call options by funds: $4.13M | Put options by funds: $3.47M
8% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 13
3% less funds holding
Funds holding: 30 → 29 (-1)
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$2.59M |
| 2 |
Millennium Management
New York
|
+$601K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$600K |
| 4 |
Morgan Stanley
New York
|
+$473K |
| 5 |
Renaissance Technologies
New York
|
+$275K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.28M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$629K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$476K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$295K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$255K |
NMRD Hedge Fund Activity: Q2 2021 in Review
29 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2021, worth a combined $10.8M — up 31% from $8.25M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NMRD and 12 opened new positions — a net loss of 1 holder — while 12 trimmed existing stakes and 4 added.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $2.59M. The largest seller was BlackRock, cutting an estimated $3.28M.
- 29 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2021, down from 30 in Q1 2021.
- Funds reported $10.8M of Nemaura Medical, Inc. Common Stock stock for Q2 2021, up 31% quarter-over-quarter.
- 12 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2021 and 13 closed out, a net change of -1 holder.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2021 was Russell Investments Group, an estimated $2.59M added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2021 was BlackRock, an estimated $3.28M sold.
Based on aggregated 13F filings for Q2 2021.